ReviewPreconditions for efficiency and affordability in competitive healthcare markets: Are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
Introduction
In the mid-1990s five countries with a social health insurance system – Belgium, Germany, Israel, the Netherlands and Switzerland – have introduced elements of regulated competition in healthcare by giving people a guaranteed periodic choice among risk-bearing health insurers (sometimes called sickness funds). The rationale of this arrangement is to stimulate the insurers to improve efficiency in healthcare production and to respond to consumer's preferences [1]. Although not in all five countries the aim of the 1990-reforms was to (also) have competition among healthcare providers, in the last decade in all five countries competition among healthcare providers has either been stimulated or seriously been discussed and proposed. Given that market failure is inherent to healthcare markets [2] and given the general perception in many societies that basic healthcare ought to be affordable for everyone, competition in healthcare has to be regulated to achieve society's goals of efficiency and affordability. Therefore it is interesting to know to what extent in these countries the necessary preconditions are fulfilled for the market to produce efficient and affordable care.
The efficiency goal relates to technical and allocative efficiency of the provision of care covered by the basic package as well as to its dynamic efficiency (for these concepts see e.g. [3], [4]) and to the efficiency of the provision of basic insurance. With affordability we mean that everyone has access to affordable health insurance covering a basic care package of services of acceptable quality within reasonable travel time and without undue waiting time. So our definition of affordability includes accessibility. The specific interpretation and definition of efficiency and affordability depend on society's norms and values.
The aim of this paper is to identify the most important preconditions for achieving efficiency and affordability under regulated competition in healthcare, and to indicate to what extent these preconditions are fulfilled in the above mentioned five countries. In this paper competition refers to both competition in the health insurance market and the healthcare provision market. Our results may be worthwhile for other countries (considering) implementing regulated competition in healthcare (e.g. Australia, Czech Republic, Ireland, Russia, Slovakia, US).
Section snippets
Ten preconditions
The theory behind the model of regulated (or managed) competition was developed and elaborated by Enthoven [5], [6], [7], [8]. This theory relates to so-called integrated delivery systems, i.e. vertically integrated organizations who are both insurer and provider of care, as well as to competing insurers and competing providers of care who contract with each other. So this theory relates to both insurer competition and provider competition. From his theoretical model we derive the following ten
Are the preconditions fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
In this section we will indicate the extent to which each of the ten preconditions is fulfilled in each of the five countries in 2012. For Germany we only concentrate on the mandatory social health insurance segment (about 90% of the population).
The findings are summarized in Table 1, Table 2, Table 3, Table 4, Table 5, Table 6, Table 7, Table 8, in which for each country is summarized which aspects of each precondition have been implemented and in what way. In addition we provide a subjective
Conclusion and discussion
In this paper we have evaluated to what extent the preconditions for achieving efficiency and affordability derived from the theoretical model of regulated competition [5], [6], [7], [8] are fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland. In this paper competition refers to both competition in the health insurance market and the healthcare provision market. These preconditions relate to the regulatory regime and institutional/structural aspects of the healthcare system
References (49)
- et al.
Risk adjustment and risk selection on the sickness fund insurance market in five European countries
Health Policy
(2003) - et al.
Information and consumer choice: the value of publicized health plan ratings
Journal of Health Economics
(2006) - et al.
Start spreading the news: a structural estimate of the effects of New York hospital report cards
Journal of Health Economics
(2008) - et al.
Choice, price competition and complexity in markets for health insurance
Journal of Economic Behavior & Organization
(2009) - et al.
Access to coverage for high-risk consumers in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies?
Journal of Health Economics
(2000) - et al.
Risk adjustment and risk selection in Europe: six years later
Health Policy
(2007) - et al.
Risk adjustment and risk sharing: the Israeli experience
Health Policy
(2003) Uncertainty and the welfare economics of medical care
American Economic Review
(1963)- et al.
Definitions of efficiency
British Medical Journal
(1999) - et al.
Waste in the U.S. healthcare system: a conceptual framework
The Milbank Quarterly
(2008)
Consumer-Choice Health Plan; a national-health-insurance proposal based on regulated competition in the private sector
New England Journal of Medicine
Managed competition of alternative delivery systems
Journal of Health Politics, Policy and Law
Theory and practice of managed competition in healthcare financing
Health care, the market and consume choice
Economics of health and health care
Public reporting of provider performance: can its impact be made greater?
Annual Review Public Health
Quality and consumer decision making in the market for health insurance and healthcare services
Medical Care Research and Review
Systematic review: the evidence that publishing patient care performance data improves quality of care
Annals of Internal Medicine
Informing consumer decisions in health care: implications from decision-making research
The Milbank Quarterly
Information and competitive price systems
American Economic Review
Hospital performance reports: impact on quality, market share, and reputation
Health affairs
Hitting and missing targets by ambulance services for emergency calls: effects of different systems of performance measurement within the UK
Journal of the Royal Statistical Society A
Is more information better? The effects of “report cards” on health care providers
Journal of Political Economy
When choice is demotivating: can one desire too much of a good thing?
Journal of Personality and Social Psychology
Cited by (96)
Perceived barriers and facilitators of structural reimbursement for remote patient monitoring, an exploratory qualitative study
2023, Health Policy and TechnologyTowards population-based payment models in a multiple-payer system: the case of the Netherlands
2022, Health PolicyCitation Excerpt :A large share of those purchasing agreements are typically based on a catalogue of fee-for-service-like payment structures, which are tied to volume of care. The Netherlands has been considered a frontrunner in the implementation of managed competition [2]. Despite some concerns, such as selection of favourable risks and information asymmetry [3], the introduction of managed competition seems to have been quite successful in controlling expenditures [4,5].